Satoshi Takenaka

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 10

Top Topics

Histone Deacetylase

Top Venues

Current oncology (Toronto, Ont.)

Cancer research communications

This page only lists publications with an associated author ORCID identifier.

Publications

Tomoki Nakamura, Satoshi Takenaka, Hidetatsu Outani, Tomohito Hagi, Hironari Tamiya, Yoshinori Imura, Kunihiro Asanuma, Akihiro Sudo
The Combined Use of Inflammation Markers, Modified Glasgow Prognostic Score, and Sarculator Nomogram in Extremity Soft Tissue Sarcoma: A Multicenter Observational Study. Cancers 16 (5) (2024)
Tomoki Nakamura, Satoshi Takenaka, Hidetatsu Outani, Tomohito Hagi, Hironari Tamiya, Yoshinori Imura, Kunihiro Asanuma, Akihiro Sudo
The Combined Use of Inflammation Markers, Modified Glasgow Prognostic Score, and Sarculator Nomogram in Extremity Soft Tissue Sarcoma: A Multicenter Observational Study. Cancers 16 (5) (2024)
Hironari Tamiya, Naoko Urushihara, Kazuko Shizuma, Hisataka Ogawa, Sho Nakai, Toru Wakamatsu, Satoshi Takenaka, Shigeki Kakunaga
SHARPIN Enhances Ferroptosis in Synovial Sarcoma Cells via NF-κB- and PRMT5-Mediated PGC1α Reduction. Cancers 15 (13) (2023)
Hirokazu Mae, Hidetatsu Outani, Yoshinori Imura, Ryota Chijimatsu, Akitomo Inoue, Yuki Kotani, Naohiro Yasuda, Sho Nakai, Takaaki Nakai, Satoshi Takenaka, Seiji Okada
Targeting the Clear Cell Sarcoma Oncogenic Driver Fusion Gene EWSR1::ATF1 by HDAC Inhibition. Cancer research communications 3 (7) (2023)
Yoshinori Imura, Satoshi Takenaka, Hidetatsu Outani, Takaaki Nakai, Naohiro Yasuda, Sho Nakai, Toru Wakamatsu, Hironari Tamiya, Seiji Okada
Impact of Surgery and Chemotherapy on Metastatic Extrauterine Leiomyosarcoma. Current oncology (Toronto, Ont.) 29 (4) (2022)
Tomoki Nakamura, Akihiko Matsumine, Yu Toda, Satoshi Takenaka, Hidetatsu Outani, Tomohiro Fujiwara, Yoshihiro Nishida, Satoshi Tsukushi, Yasunori Tome, Teruya Kawamoto, Munehisa Kito, Naohiro Shinohara, Masato Tomita, Tomoaki Torigoe, Akihiro Sudo, Hirotaka Kawano
Long-Term Results of Kyocera Modular Limb Salvage System after Resection of Tumors in the Distal Part of the Femur: Report from Japanese Musculoskeletal Oncology Group Study. Cancers 14 (4) (2022)
Hidetatsu Outani, Satoshi Takenaka, Kenichiro Hamada, Yoshinori Imura, Shigeki Kakunaga, Hironari Tamiya, Toru Wakamatsu, Norifumi Naka, Takafumi Ueda, Nobuhito Araki
A long-term follow-up study of extracorporeal irradiated autografts in limb salvage surgery for malignant bone and soft tissue tumors: A minimum follow-up of 10 years after surgery. Journal of surgical oncology 121 (8) (2020)
Satoshi Takenaka, Nobuhito Araki, Hidetatsu Outani, Ken-Ichiro Hamada, Hideki Yoshikawa, Tadashi Kamada, Reiko Imai
Complication rate, functional outcomes, and risk factors associated with carbon ion radiotherapy for patients with unresectable pelvic bone sarcoma. Cancer 126 (18) (2020)
Satoshi Takenaka, Nobuhito Araki, Takafumi Ueda, Shigeki Kakunaga, Yoshinori Imura, Ken-Ichiro Hamada, Hidetatsu Outani, Norifumi Naka, Akira Myoui, Hideki Yoshikawa
Clinical Outcomes of Osteoarticular Extracorporeal Irradiated Autograft for Malignant Bone Tumor. Sarcoma 2020 (2020)
Sho Nakai, Hironari Tamiya, Yoshinori Imura, Takaaki Nakai, Naohiro Yasuda, Toru Wakamatsu, Takaaki Tanaka, Hidetatsu Outani, Satoshi Takenaka, Kenichiro Hamada, Akira Myoui, Nobuhito Araki, Takafumi Ueda, Hideki Yoshikawa, Norifumi Naka
Eribulin Suppresses Clear Cell Sarcoma Growth by Inhibiting Cell Proliferation and Inducing Melanocytic Differentiation Both Directly and Via Vascular Remodeling. Molecular cancer therapeutics 19 (3) (2019)